We are live on
!
Find out more
2L
22NW LP Portfolio holdings
AUM
$146M
1-Year Est. Return
29.83%
This Fund
S&P 500
This Quarter
Est. Return
+12.51%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
–
AUM
$88.1M
AUM Growth
+$12.3M
(+16%)
Cap. Flow
+$5.34M
Cap. Flow
% of AUM
6.06%
Top 10 Holdings %
Top 10 Hldgs %
72.25%
Holding
35
New
11
Increased
7
Reduced
3
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medifast
MED
|
+$1.54M |
| 2 |
TripAdvisor
TRIP
|
+$1.35M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$1.31M |
| 4 |
GIFI
Gulf Island Fabrication
GIFI
|
+$1.15M |
| 5 |
LOGM
LogMein, Inc.
LOGM
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIOT
PowerFleet Inc
AIOT
|
+$2.08M |
| 2 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$1.92M |
| 3 |
Dollar Tree
DLTR
|
+$1.37M |
| 4 |
TransAlta
TAC
|
+$965K |
| 5 |
DXC Technology
DXC
|
+$719K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 26.93% |
| 2 | Industrials | 16.02% |
| 3 | Healthcare | 14.49% |
| 4 | Consumer Discretionary | 11.47% |
| 5 | Technology | 11.26% |
Similar funds
TA
AFM
SCM
AWM
AGP
SIM
AC
ECM
22NW LP's Q4 2019 Portfolio in Review
As of Q4 2019, 22NW LP held 35 positions worth $88.1M, up 16% from $75.8M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
22NW LP deployed $5.34M of net new capital in Q4 2019, opening 11 new positions and adding to 7 existing holdings. Its largest new stake was Medifast: 15,961 shares worth $1.75M.
By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was PowerFleet Inc, an estimated $2.08M trimmed.
- 22NW LP's largest Q4 2019 buy was Medifast: 15,961 shares worth $1.75M.
- 22NW LP added most to Gulf Island Fabrication in Q4 2019, an estimated $1.15M increase.
- 22NW LP's biggest Q4 2019 reduction was PowerFleet Inc, cutting an estimated $2.08M.
- 22NW LP fully exited Strongbridge Biopharma plc. in Q4 2019, selling an estimated $1.92M.
- 22NW LP's ten largest holdings make up 72% of its $88.1M portfolio in Q4 2019.
- 22NW LP opened 11 new positions and closed 7 in Q4 2019.
- 22NW LP's portfolio value rose 16% quarter-over-quarter to $88.1M.
Based on 22NW LP's 13F filing for Q4 2019, filed 14 Feb 2020.